BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Pharmacokinetics
- First Posted Date
- 2016-11-06
- Last Posted Date
- 2017-04-24
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16
- Registration Number
- NCT02957396
Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Pharmacokinetics
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16
- Registration Number
- NCT02956109
Drug Use Investigation of Kovaltry in Hemophilia A Patients
Active, not recruiting
- Conditions
- Hemophilia A
- Interventions
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 231
- Registration Number
- NCT02941783
- Locations
- 🇯🇵
Many Locations, Multiple Locations, Japan
BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
Phase 1
Completed
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 23
- Registration Number
- NCT02940002
Sun Protection Factor Assay (SPF Assay 204/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987521
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 11
- Registration Number
- NCT02936544
Sun Protection Factor Assay (SPF Assay 206/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987521
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 5
- Registration Number
- NCT02936570
BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study
Phase 1
Terminated
- Conditions
- Psoriasis
- Interventions
- Drug: BAY1003803 0.01% lipophilic creamDrug: Lipophilic cream vehicleDrug: BAY1003803 0.1% lipophilic creamDrug: Ointment vehicleDrug: BAY1003803 0.01% ointmentDrug: BAY1003803 0.1% ointment
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2017-11-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 32
- Registration Number
- NCT02936492
Sun Protection Factor Assay (SPF Assay 207/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987521
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 6
- Registration Number
- NCT02936583
Sun Protection Factor Assay (SPF Assay 205/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987521
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 11
- Registration Number
- NCT02936557
Sun Protection Factor Assay (SPF Assay 201/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987516
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 11
- Registration Number
- NCT02930772
© Copyright 2025. All Rights Reserved by MedPath